Apotheca Earth Biosciences is developing cutting-edge nutraceuticals, pharmaceuticals and delivery technologies for the healthcare and consumer care industry. Our pipeline of products includes, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids.

TRANSDERMAL DELIVERY TECHNOLOGIES

  • CannaDerm – a Liposomal-based nanaemulsion for controlled release in a Thermo-sensitive gel technologies for sustained release.
  • Canna-AcnePlus – Acne – utilizing a liposomal-based nanoemulsion, this formula is excellent at cleansing one’s skin.
  • Canna-Derme AD – Atopic Dermatitis – a stronger and more potent version of CannaDerm with additional chemistry to ensure inflammation reduction.
  • Canna-EyeSol – Dry eyes – A drip solution that alleviates eye pressure and increases clarity.

Medical Product Pipeline

SUBLINGUAL RAPID DELIVERY TECHNOLOGY

  • CannaRapid – Orally disintegrating tablets ensuring increased bioavailiability for capillary uptake and immediate response.
  • Canna-OraGel – Periodontitis – gel designed with liposomal cannabinoids to aid in gum health. Apotheca Oral care line: Healthy teeth and gum tissues
  • Canna-OraSol – Dry Mouth – a solution with a phytocannabinoid nanoemulsion to increase saliva production. Apotheca Oral care line: Healthy teeth and gum tissues
  • DAVA-INGREDIENTS – Tincture Alcohol, 400mg’s hemp-derived CBD, natural flavors
Consumercare Product Pipeline
  • FDA DISCLOSURE – These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
  • EU IMPORT – Our CBD is hemp derived from EU certified hemp seeds, sustainably grown and CO2 extracted before being imported to the USA from the EU.
  • QUALITY GUARANTEED – Certificate of Analysis available for every batch upon request.
  • CONTENTS – 20 ml Amber glass bottle, with tamper proof lid, & bulb dropper for precision measurement.

NASAL DELIVERY TECHNOLOGIES

  • NasaCann – Direct brain delivery via inhalable cannabinoid nanoparticles.

Medical Product Technologies

Molecule Model

One of the major issues in cannabis use for medical purpose is the precise dosing and delivery technology. As a scientific team, Apotheca is taking on to that challenge; with our in-house engineering and cannabis science expertise, we have developed various delivery and device technologies which will have a far-reaching impact on how to effectively deliver a precise dose of cannabis compounds to patients. Apotheca’s canna-pipeline of products includes transdermal, sublingual, and nasal targeted delivery of cannabinoids with novel formulation technologies.

Apotheca has developed three core platform technologies; CannaRAPID™CannaNASAL™and CannaDERME™ focused on precise dosing and controlled release of cannabinoid compounds for patients. The technologies and formulations of these technologies are completed a d several application areas and medical products based on these core-technologies are being developed for various indications.

CannaRAPID™: Proprietary sublingual delivery technologies using orally disintegrating tablet technology.

There are several inherent benefits of sublingual delivery of drugs such as fast absorption, avoidance of unwanted liver and gut microbiota metabolism on active drug. Further, as medical cannabis is going to be in mainstream medicine, there is an urgent need for a new dosage and delivery form that can improve patient compliance. Common complaints about the difficulty in swallowing tablets in the order of frequency of complaints are size, surface, form, and taste of tablets are common in various patient groups. Geriatric and pediatric patients and traveling patients who may not have ready access to water are most in need of easy swallowing dosage forms.

Almost 50% of people suffer from some form of dysphagia, or difficulty in swallowing. Solid dosage forms that can be dissolved or suspended with water in the mouth for easy swallowing are highly desirable for the pediatric and geriatric population, as well as other patients who prefer the convenience of readily administered dosage forms and that is a reason why we come up with CannaRAPID” he added.

Apotheca Biosciences’ sublingual product, CannaRAPID is a sugar-free Orally Disintegrating Tablet to deliver a precise dose of cannabinoids to neural tissues in a matter of seconds. The formulation is optimized with nanotechnology and tissue permeation enhancing molecules for faster absorption. Apotheca Biosciences pairing up with clinical organizations and various clinical practitioners for conducting clinical studies using CannaRAPID for various indications such as stress and anxiety relief, cognitive focus, various kinds of pain, migraines etc

Couple

Application Areas

Opioid Addiction in US CannaRAPID™ might be the answer for treating opioid addiction

United States is in the middle of an unprecedented opioid epidemic; Since 1999, the rate of overdose deaths involving opioids nearly quadrupled, and over 165,000 people have died from prescription opioid overdoses. Prescription pain medication deaths remain far too high, and in 2014, the most recent year on record, there was a sharp increase in heroin-involved deaths and an increase in deaths involving synthetic opioids such as fentanyl. Prevention, treatment, and research to rapidly tackle and reverse opioid overdoses are critical to fighting this epidemic.

Early data coming out of states where marijuana laws have been passed suggest that even as conventionally used, marijuana may be playing a role in offsetting the opioid addiction epidemic. Studies have shown that phytocannabinoids like cannabidiol have promising results in opioid withdrawal symptoms and heroin-seeking behavior.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi hendrerit elit turpis, a porttitor tellus sollicitudin at. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Our studies have shown that cannabidiol can have promising improvements in opioid withdrawal symptoms by attenuating the rewarding effects of opioids. There is at least partial evidence that cannabinoid compounds can relieve from depression. Apotheca Biosciences is partnering with opioid addiction centers and clinical practitioners to conduct studies on the use of CannaRAPID for opioid addiction.

“Data is showing that on an average day in US about 78 people die from an opioid-related overdose, most of the ones died belongs to the younger population” said Bobban Subhadra, M.S., Ph.D, CEO at Apotheca Earth. “This is a serious epidemic that need to be dealt with a high level of urgency; we are talking about teens who are the future of our nation dying in high numbers on our streets. That is the reason, why we at Apotheca Earth, wanted to seriously investing in the application of our CannaRAPID as a possible intervention for opioid addiction. Even if we can save one young life with our CannaRAPID sublingual technology, we will take it as a enormous success” he added.

Apotheca Biosciences sublingual product, CannaRAPID is a sugar-free Orally Disintegrating Tablet to deliver precise dose cannabinoids to neural tissues in a matter of seconds. The formulation is optimized with nanotechnology and tissue permeation enhancing molecules for faster absorption. There are several inherent benefits of sublingual delivery of drugs such as fast absorption, avoidance of unwanted liver and gut microbiota metabolism of active drug. Further, as medical cannabis is going to be on mainstream medicine, there is an urgent need for a new dosage and delivery form that can improve patient compliance.

Apotheca Biosciences is pairing up with clinical organizations and various clinical practitioners for conducting clinical studies on the use of CannaRAPID as an adjunct therapy for opioid addiction. Our preliminary studies show that opioid doses can be significantly reduced by the use of CannaRAPID. It has two synergistic benefits: CBD reduces opioid addiction signaling pathway by working in the brain addiction reward system while simultaneously helps to alleviate pain.

CannaDERME™Transdermal technology using nano-emulsion for fast absorption of cannabinoid compounds.

The CannaDERME has transcutaneous cannabinoid penetration technology coupled with nano-emulsion for sustained release of compounds for longer time. The formulation delivers therapeutic doses to target areas (e.g. brain stem, cuteneous sympathetic nervous system)for whole-body effect. Cutaneous neuromediators include classical neurotransmitters, such as the catecholamines and acetylcholine, which are released from the automatic nervous

system or cutaneous cells. Skin being the largest organ, it has the potential to permeate effective doses to specific target organs as well as to systemic circulation without first pass gut metabolism.

Application Areas:

Apotheca Biosciences is partnering up with physician groups for conducting clinical studies using CannaDerme line for various indications (Chronic pain, Acne, Atopic Dermatitis).

CannaNASAL™: Nasal delivery technology using liposomal nanoparticles

Application Areas:

Allergic rhinitis

Nutraceutical Product Technologies

Hemp Bar Banner

Health Hemp Bar:

With a partner company Apotheca has developed the most healthiest CBD Hemp bar which has numerous health benefits.This is a functional food with added benefits of CBD.

Key feature of Health Hemp Bar:

  • 50mg CBD/bar
  • All natural ingredients
  • Non-GMO
  • No Added Sugars
  • 7-8 gram protein
  • All plant protein
  • Key micronutrients (Vitamins & Minerals)
Hemp Oil being applied

SmartHealth CBD Oil

Our formulator has developed the most healthiest CBD Oil for the total health of various groups of consumers. The type of oil base we choose matters. Replacing saturated fat with sources of monounsaturated fat can help maintain heart health and healthy blood pressure*, as well as helping to maintain healthy blood sugar levels*.

Key feature of SmartHealth CBD Oil

  • 20- 50mg CBD/ml
  • All natural ingredients
  • Non-GMO
  • Highest level health Enhancing monosaturated fatty acid (85-90%)
  • Less than 4% saturated fatty acid
  • Omega-3 fatty acid (DHA and EPA) to confer cardio and neural health

Further, we have added Omega-3 fatty acid that will synergistically act with CBD to deliver health benefits. Our oil base has the lowest levels of saturated fat than any other oil base– with 75% less saturated fat than olive oil and avocado oil. As a source of good monounsaturated fat, it is a simple and delicious swap that can replace sources of saturated fat to help maintain heart health.

No Comments

Comments are closed.